Komipharm International Co. Ltd
Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. It also develops anticancer drugs and pain-relieving agents, which include Kominox, an arsenic-based oral drug; and Panaphix, a non-narcotic cancer pain reliever, as well as provides clinical pathological experiment, test, and analysis se… Read more
Komipharm International Co. Ltd (041960) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.002x
Based on the latest financial reports, Komipharm International Co. Ltd (041960) has a cash flow conversion efficiency ratio of -0.002x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-178.43 Million) by net assets (₩74.86 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Komipharm International Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Komipharm International Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Komipharm International Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Komipharm International Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zoneco Group Co Ltd
SHE:002069
|
0.227x |
|
Great Giant Fibre Garment Co., Ltd.
TWO:4441
|
-0.043x |
|
EZTEC Empreendimentos e Participações S.A
SA:EZTC3
|
0.042x |
|
Investar Holding Corp
NASDAQ:ISTR
|
0.023x |
|
Comp SA
WAR:CMP
|
0.041x |
|
Skyworth Group Limited
PINK:SWDHF
|
0.047x |
|
Shanghai Weihong Electronic Technology Co Ltd
SHE:300508
|
0.035x |
|
Odfjell SE
OL:ODF
|
0.313x |
Annual Cash Flow Conversion Efficiency for Komipharm International Co. Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Komipharm International Co. Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩65.54 Billion | ₩8.85 Billion | 0.135x | +389.35% |
| 2023-12-31 | ₩60.02 Billion | ₩-2.80 Billion | -0.047x | -56.46% |
| 2022-12-31 | ₩60.63 Billion | ₩-1.81 Billion | -0.030x | -57.78% |
| 2021-12-31 | ₩66.46 Billion | ₩-1.26 Billion | -0.019x | -5819.79% |
| 2020-12-31 | ₩76.28 Billion | ₩25.20 Million | 0.000x | -97.45% |
| 2019-12-31 | ₩73.28 Billion | ₩950.79 Million | 0.013x | +160.06% |
| 2018-12-31 | ₩93.39 Billion | ₩-2.02 Billion | -0.022x | -1028.56% |
| 2017-12-31 | ₩101.27 Billion | ₩235.64 Million | 0.002x | -82.06% |
| 2016-12-31 | ₩93.20 Billion | ₩1.21 Billion | 0.013x | +133.70% |
| 2015-12-31 | ₩76.13 Billion | ₩-2.93 Billion | -0.038x | +19.33% |
| 2014-12-31 | ₩53.16 Billion | ₩-2.54 Billion | -0.048x | -154.21% |
| 2013-12-31 | ₩44.72 Billion | ₩3.93 Billion | 0.088x | -- |